Aviado · Research
Longevity Daily
Monday, August 17, 2026
Listen
Today's Brief
The aging immune system takes center stage today — its failure to clear senescent cells appears to be a primary driver of Alzheimer's and tissue decline more broadly. Today's must-read covers the Mayo Clinic's ALSENLITE trial, where the senolytic duo of dasatinib and quercetin demonstrated a real ability to remove senescent cells from Alzheimer's brains. Metformin's newly discovered brain effects, a cheap 1970s cholesterol drug that mimics caloric restriction, and The Independent's sharp case for VO2 max as your top longevity metric all add depth to today's issue. Aviado Research's latest review rounds out a strong edition.
10 stories4 peer-reviewed1 trials1 Aviado original
Cognitive Health & Neuroprotection
Mayo Clinic's Senolytic Duo Clears Senescent Cells From Alzheimer's Brains
The Mayo Clinic's ALSENLITE trial (NCT04785300) has produced a significant clinical finding: the combination of dasatinib, a cancer drug, and quercetin, a widely available plant compound, can demonstrably clear senescent 'zombie' cells from the brains of individuals with mild cognitive impairment and Alzheimer's disease. These cells accumulate in aging brains, pumping out inflammatory signals that accelerate neurodegeneration — and this marks the first clinical evidence that senolytics can reach and clear them in actual patients, not just mice. For the 7 million Americans living with Alzheimer's, this is a genuine mechanism-level advance distinct from the long line of failed amyloid interventions. Quercetin is available as a supplement, but dasatinib requires a prescription — discuss with your physician before considering either.
Read more →Aging Immune Systems Lose the Ability to Eliminate 'Zombie' Cells — and That May Drive Everything
A growing body of research confirms a troubling feedback loop: as your immune system ages, it becomes less capable of clearing senescent cells, which then accumulate and produce chronic inflammation that further degrades immune function. Fight Aging! breaks down the mechanisms behind this collapse of immunosurveillance and what research groups are doing to restore clearance capacity, from senolytics to NK cell-based therapies. If you're trying to understand why your anti-aging interventions seem to hit a ceiling past a certain age, this is part of the mechanistic explanation.
Read more →Metformin's 'Hidden Brain Effects' Are Now Under the Microscope
Scientists are investigating neurological effects of metformin that extend well beyond blood sugar regulation — and they aren't all positive. The Mirror reports new findings suggesting metformin influences brain chemistry in ways that weren't previously well characterized, with implications for both diabetic patients and the fast-growing population taking it off-label for longevity. If you're in the latter camp, understanding the full cognitive profile of this drug is essential context before continuing use.
Read more →Supplements & Compounds
Neuriva Is One of America's Best-Selling Brain Supplements — Does the Evidence Match the Marketing?
Pharmacy Times takes a hard look at Neuriva, the celebrity-endorsed cognitive supplement stocked in virtually every drugstore chain in the country, and finds a significant gap between claims and data. Schiff Vitamins markets five cognitive benefits — memory, accuracy, learning, focus, and concentration — but these claims haven't been evaluated by the FDA, and the underlying evidence for the ingredient stack is considerably thinner than the packaging implies. If you're spending $30 or more a month on this product, read this before your next purchase.
Read more →A Cheap 1970s Cholesterol Drug Tricks Cells Into 'Thinking' They're Fasting — and Extends Lifespan in Animal Models
A large international research team has found that gemfibrozil — a fibrate prescribed since the 1970s to lower blood fats, available at a fraction of the cost of newer longevity drugs — extends lifespan in yeast and worms and measurably improves health markers in aged mice. The mechanism involves activating cellular pathways associated with caloric restriction and AMPK signaling, similar to how metformin works. This remains preclinical with no human trial data, but gemfibrozil's decades-long safety record makes it one of the more credible drug-repurposing candidates in the longevity pipeline worth watching.
Read more →Research & Papers
Nature Medicine Says We're Misusing Biological Age Clocks — Here's What You Should Know
A new Nature Medicine commentary — highlighted by chronobiology pioneer Satchin Panda — argues that 'biological age' clocks are being misapplied in both research and consumer settings, often conflating what these tests actually measure with what people hope they mean. The proliferation of commercial epigenetic clocks and biological age scores has significantly outpaced the validation science behind them. If you've paid for a biological age test or track your epigenetic age as a health metric, this is essential reading for calibrating your expectations.
Read more →A Scientist Ran the Most Comprehensive Longevity Protocol on Himself for 7 Months and Tracked Every Biomarker
Researchers at the National University of Singapore designed the DELTA protocol — an intensive combination of time-restricted eating, repeated 48-hour water fasts, strength and interval training, a Mediterranean-style diet, and an earlier sleep schedule — then ran it on a single healthy volunteer who happened to be the study's own senior author. Detailed blood biomarker tracking recorded the biological response to this combined intervention over seven to nine months. This is inherently an n=1 study with obvious self-report limitations, but it represents one of the most granular attempts yet to measure how a comprehensive lifestyle longevity stack changes the body in real time.
Read more →Aviado Research Review: Cutting Through the Longevity Noise
Aviado's latest research review applies a structured, citation-backed framework to separate signal from noise in the longevity intervention landscape — providing the kind of rigorous, referenced analysis that's largely absent from consumer health media. As a living document updated with evolving findings, it serves as a durable reference for readers who want to go deeper than the headlines.
Read the full Aviado analysis →Lifestyle & Nutrition
VO2 Max: The Single Fitness Metric Longevity Experts Say Predicts Your Lifespan Better Than Almost Anything Else
The Independent's first-person account of undergoing VO2 max testing doubles as a sharp primer on why experts including Dr. Andy Galpin and Peter Attia consider it the gold standard predictor of longevity and all-cause mortality risk. The important upside: unlike many health biomarkers, VO2 max is highly trainable — even modest improvements through consistent zone 2 cardio can move you meaningfully up the percentile charts. This piece gives you the context to understand your own number and a clear framework for improving it.
Read more →Mark Hyman Makes the Case That Muscle Is the Most Overlooked Longevity Organ
Dr. Mark Hyman argues that skeletal muscle — not the heart or the brain — is the most underappreciated system for longevity, citing a 2026 JAMA Network Open study linking muscular strength directly to mortality risk in women aged 63 to 99. Muscle acts as a metabolic sink for glucose, an amino acid reservoir during illness, and the primary driver of mitochondrial biogenesis — making it a uniquely powerful longevity lever at any age. The takeaway is actionable: if resistance training isn't already central to your health protocol, this is the most compelling evidence yet that it should be.
Read more →